Special Allergen Service
Unique and customized products services
Thermo Fisher Scientific enables customers to keep their laboratory on the cutting edge of allergy research.
With 50 years of experience in IgE detection and immunoassay development, we can offer a range of services using our unique knowledge and expertise to quantify immune response for your specific needs. At times, a test may be needed for rare allergens, antigens, or those not yet commercially available.
Thermo Fisher Scientific offers:
Allergy research:1-4
- Rare allergens and customized ImmunoCAP™ tests.
- Requests on coupling of novel allergens.
- Research collaborations using emerging allergens.
Customized products for the manufacturing industry:5
Follow-up of occupational allergen sensitization for the manufacturing industry, e.g., sensitization to enzymes handled in factories.
Customized products for biopharma:6,7
Immunogenicity testing of biologics, e.g., sIgE*, sIgG*, and sIgG4 to biological drugs in clinical studies and post market surveillance.
Products from Special Allergen Service are always for research use only (RUO) and should be validated for their intended use. Contact your local representative for more information.
*Regulatory status and commercial availability of products varies across countries. Contact your local Thermo Fisher Scientific representative to confirm availability.
Contact your local Thermo Fisher Scientific representative to learn more about Special Allergen Service.
These products may not be cleared for use in your country. Please contact your sales representative for information about specific product availability.
Thermo Fisher Scientific is a global leader in allergy and autoimmune diagnostics.
Support
Along with practice parameters and guidelines for clinicians, Thermo Fisher Scientific provides clinical and laboratory training and support, including enhanced clinical insights beyond results.
50 years
Phadia AB, owned by Thermo Fisher Scientific, has provided continuous diagnostic innovations for more than five decades.
- Rolla G., et al. Pigeon tick bite: A neglected cause of idiopathic nocturnal anaphylaxis. https://www.ncbi.nlm.nih.gov/pubmed/29083476
- Athina L. Van Gasse, et al. Specific IgE to cefazolin: Does it benefit diagnosis? https://www.jaci-inpractice.org/article/S2213-2198(19)30492-1/abstract
- Troy Wanandy, Et al. Towards complete identification of allergens in Jack Jumper (Myrmecia pilosula) ant venom and their clinical relevance: An immunoproteomic approach https://onlinelibrary.wiley.com/doi/abs/10.1111/cea.13224
- Decuyper II, et al. Cannabis allergy: what the clinician needs to know in 2019. https://www.ncbi.nlm.nih.gov/pubmed/30946607
- A. Ingemann Larsen, et al. Allergy Development in Adulthood: An Occupational Cohort Study of the Manufacturing of Industrial Enzymes https://www.sciencedirect.com/science/article/pii/S2213219819305586?via%3Dihub
- L Winstedt, et.al. Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase 1 Study with Bacterial Enzyme IdeS – A Novel Therapeutic Oppurtunity. PLOS ONE. 2015. https://www.ncbi.nlm.nih.gov/pubmed/26177518
- Dohan K. Weeraratne, et al. Measurement of Anti-Erythropoiesis-Stimulating Agent IgG4 Antibody as an Indicator of Antibody-Mediated Pure Red Cell Aplasia. Clinical and Vaccine Immunology 2013;20(1):46–51. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535764/
